Management of acute mania

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 5, 1999, Pages 31-36

  Tohen, Mauricio ^a,b   Grundy, Starr ^b  

^a MCLEAN HOSPITAL   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; ALGORITHMS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CARBAMAZEPINE; CLINICAL TRIALS; HUMANS; LITHIUM; PIRENZEPINE; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME; TREATMENT REFUSAL; VALPROIC ACID;

EID: 0032961578     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: E & S Livingstone; 1921
2. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41:934-941
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Study. Arch Gen Psychiatry 1994;51:8-19
4. Tohen M, Goodwin FK. Psychiatric epidemiology. In: Tsuang MT, Tohen M, Zahner G, eds. Psychiatric Epidemiology. New York, NY: John Wiley & Sons; 1995:301-316
5. Stoll AL, Tohen M, Baldessarini RJ, et al. Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry 1993;150:1669-1673
6. Tohen M, Mania. In: Sederer LI, Rothschild AJ, eds. Acute Care Psychiatry: Diagnosis and Treatment. Baltimore, Md: Williams & Wilkins; 1997: 141-165
7. Weissman MM, Merikangas KR, Risch NJ. Comorbidity and co-transmission of alcoholism, anxiety and depression. Psychol Med 1994;24:69-80
8. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
9. Tohen M, Zarate CA Jr, Zarate SB, et al. The McLean/Harvard First Episode Mania Project: pharmacologic treatment and outcome. Psychiatr Ann 1996;26:1-5
10. Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992;149:1580-1584
11. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-1111
12. Hirschfeld RMA, Clayton PJ, Cohen I, et al. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(12, suppl):1-36
13. VanGent EM, Zwart FM. Psychoeducation of partners of bipolar manic patients. J Affect Disord 1991;21:15-18
14. Winokur G, Coryell W, Keller M, et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993;50:457-465
15. Baldessarini RJ, Tondo L, Suppes T, et al. Pharmacological treatment of bipolar disorder throughout the life cycle. In: Shulman KI, Tohen M, Kutcher S, eds. Mood Disorders Throughout the Life Span. New York, NY: John Wiley & Sons; 1996
16. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
17. Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48: 62-68
18. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
19. McElroy SL, Keck PE Jr, Stanton SP, et al. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-146
20. Lambert PA, Venaud G. Etude comparative du valpromide versus lithium dans la prophylaxie des troubles thymiques. Nervure Journal de Psychiatrie 1992:1-9
21. Klien E, Beatal E, Lerer B, et al. Carbamazepine and haloperidol versus placebo and haloperidol in excited psychoses: a controlled study. Am J Psychiatry 1984;137:782-790
22. Post RM, Uhde TW, Roy-Byrne PP, et al. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83
23. Frankenburg FR, Tohen M, Cohen BM, et al. Long-term response to carbamazepine: a retrospective study. J Clin Psychopharmacol 1988;8:130-132
24. Prien W, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990;26:409-427
25. Denikoff KD, Meglathery SB, Post RM, et al. Efficacy of carbamazepine compared with other agents: a clinical practice survey. J Clin Psychiatry 1994;8:130-132
26. Tohen M. The adverse effect profile and safety of divalproex. Rev Contemp Pharmacother 1995;6:587-595
27. McElroy SL, Keck PE Jr, Strakowski SM. Mania, psychosis, and antipsychotics. J Clin Psychiatry 1996;57(suppl 3):14-26
28. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
29. Tohen M, Zarate CA Jr, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-253
30. Zarate CA Jr, Narendran R, Tohen M, et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998;59:24-28
31. Tohen M, Zarate CA Jr, Sanger TM. A placebo-controlled trial of olanzapine in psychotic or non-psychotic acute mania [abstract]. Schizophr Res 1998;29:204
32. Tran PV, Dellva MA, Tollefson GD, et al. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. J Clin Psychiatry 1997;58:205-211
33. Tollefson GD, Beasley CM, Tamura RN, et al. A blinded, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesias with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248-1254
34. Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-418
35. Bosco MR, Rush AJ. Compliance with pharmacology in mood disorders. Psychiatr Ann 1995;25:269-279
36. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 1984;52: 873-878
37. VanGent EM, Zwart FM. Psychoeducation of partners of bipolar manic patients. J Affect Disord 1991;21:15-18
38. Winokur G, Coryell W, Keller M, et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993;50:457-465
39. Greenberg PE, Finkelstein SN, Berndt ER. Economic consequences of illness in the work place. Sloan Management Review 1995;36